Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus

AIMS: As metabolic remodeling is a pathological characteristic in type 2 diabetes (T2D), we investigate the roles of newly developed long-acting glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as dulaglutide and liraglutide on metabolic remodeling in patients with recent-onset T2D. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Juan, Xi, Liuqing, Zhang, Zhongxiao, Ge, Xiaoxu, Li, Wenyi, Peng, Wenfang, Jiang, Xiaohong, Liu, Wen, Zhao, Nan, Wang, Xingyun, Guo, Xirong, Huang, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846071/
https://www.ncbi.nlm.nih.gov/pubmed/36686441
http://dx.doi.org/10.3389/fendo.2022.1097612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846071/
https://www.ncbi.nlm.nih.gov/pubmed/36686441
http://dx.doi.org/10.3389/fendo.2022.1097612

Ejemplares similares